solving $1B healthcare problems that are hiding in plain sight.
We are not interested in technology that will never see the light of day in our lifetime. Suncoast backs the entrepreneurs solving the problems of our generation.
Bloomlife is transforming maternal healthcare with a remote monitoring platform designed to reduce risk, expand access, and ease the burden of high-risk pregnancy care. Starting with reimbursable solutions for hypertension and diabetes management, Bloomlife will launch the first FDA-cleared, at-home fetal non-stress test (NST) in 2026—eliminating the need for 2–3 in-clinic visits per week during the third trimester. Purpose-built for Medicaid and underserved populations, the platform combines cellular-enabled devices, automated workflows, and deep clinical validation to unlock real-time monitoring from home. In a $400B+ market plagued by outdated tools and rising maternal mortality, Bloomlife is reengineering prenatal care for the women who need it most.
Sector
Maternal Health
Date
Q3 2025
Location
San Francisco Bay Area
Co-Investors
Kapor Capital, Mark Benioff, RH Capital, Stardust Equity, The Grove Foundation, SOSV
MDisrupt is building the infrastructure for responsible health innovation—a curated expert marketplace that connects digital health, medtech, and life sciences companies with vetted clinicians, regulatory specialists, and commercialization experts. Designed for startups operating in a fast-moving, AI-enabled world, MDisrupt provides on-demand access to fractional, project-based “tiger teams” who accelerate evidence generation, compliance, and go-to-market execution. With backing from the American Heart Association, MDisrupt is powering a more efficient, credible, and scalable path for bringing healthcare innovations to market.
Sector
Infrastructure
Date
Q3 2025
Location
Austin, Tx
Co-investors
American Heart Association
The Gleamery is reimagining dental care for the modern consumer—offering a spa-like, anxiety-free experience focused exclusively on cleaning, whitening, and straightening. Designed for younger, uninsured, and dental-averse patients, Gleamery replaces drills and needles with transparent pricing, online booking, and beautifully designed studios open nights and weekends. With strong early traction, profitable unit economics, and a hygienist-led care model, Gleamery is building the first preventative-first dental brand in a $45B+ market ripe for disruption.
Sector
Consumer Health, Dental
Date
Q1 2025
Location
Los Angeles, CA
Welby Health is an AI-powered virtual care management platform that helps clinics increase revenue, reduce clinician burnout, and improve patient outcomes—without adding administrative burden. Seamlessly integrated with major EMRs, Welby automates chronic care management (CCM), remote patient monitoring (RPM), and billing workflows through its proprietary Marcus AI engine. Clinics pay nothing upfront and only share revenue once it’s generated, making adoption frictionless. With industry-leading retention, 5-star patient reviews, and a 97 Net Promoter Score, Welby is redefining how technology can support providers in delivering scalable, high-quality care.
Sector
Health Tech, Medical AI
Co-Investors
Clear Vision Equity Partners
Date
Q1 2025
Location
San Diego, CA
ClinNEXUS is delivering high-touch, tech-enabled care coordination for underserved Medicaid populations. Focused on the 5% of patients who drive the majority of healthcare costs, ClinNEXUS partners directly with managed care plans to provide Enhanced Care Management (ECM) through community-based care teams—not apps or wearables. Their human-first model is supported by smart technology and AI to streamline operations, improve outcomes, and scale efficiently.
Sector
Health Tech
Date
Q1 2025
Location
Los Angeles, CA
Theme
Health equity, care coordination, rural health
Powering generational health, Trellis is the first family-based health operating system and complete platform for personal precision health; starting with pregnancy and postpartum.
Their HIPAA compliant, native iOS is connected to 40k provider sites and can pull in 1 decade of health history in less than 1 minute using a selfie and ID. The Trellis app then creates never before seen fundamental baselines, automates summaries, and creates predictive questions to facilitate more in depth communication between patient and doctor.
Sector
Digital Health, Medical AI
Co-Investors:
Swizzle Ventures, TechStars,
Date
Q4 2024
Location
Seattle, WA
Theme
Women’s health, Medical records visualization
GritWell is an all-inclusive concierge digital health program for root cause Functional medicine. Administered by MDs, health coaches and a care team, GritWell uses a digital platform and is developing AI to automate the process of intake, analysis, and identifying the root causes which typically fall into several core categories.
Sector
Digital Health
Co-Investors:
Peterson Ventures, Alumni Ventures, Seed to B
Date
Q4 2024
Location
San Francisco Bay Area
Theme
Women’s health, Functional Medicine
Orthopedic conditions are one of the top medical costs for U.S. employers. Aware was created to help companies significantly cut costs while getting employees back to work faster by successfully triaging, diagnosing, and optimizing care delivery. Aware uses cutting-edge research to inform clinical decisions, resulting in lower utilization rates for the most costly diagnostics and treatments.
Sector
Digital Health
Co-Investors:
Boomerang VC, Bright Ventures, Tidal River Fund,
Date
Q3 2024
Location
San Francisco Bay Area
Theme
Health Access, Musculoskeletal
Next Life Sciences is modernizing reproductive healthcare starting with PlanA™, a non-invasive, pain-free, non-hormonal, permanent and easily reversible male birth control and vasectomy alternative.
Sector
Medtech
Co-Investors:
Particular Ventures, JoyFund, Transform VC, Unpopular Ventures, Startup Health
Date
Q3 2024
Location
Southern California
Theme
Global Health, Health Equity
CRISPR QC is the first CRISPR Analytics Platform that can quickly and effectively simulate gene editing under a wide variety of conditions, helping making CRISPR gene editing safe & scaleable. Customers can control and predict how their gene edits will go and what to optimize to get their desired outcomes. This allows for rapid product development and precision in therapy.
Sector
Data, Analytics
Co-Investors:
XCelerant Ventures, Serra Capital, Kereitsu
Date
Q3 2024
Location
San Diego, California
Theme
Global Health, Drug Development
Raydiant Oximetry is introducing Lumerah™, a safe, noninvasive fetal pulse oximeter that measures fetal oxygen saturation without adversely affecting the labor process. Offering greater accuracy and insight into fetal health so obstetrical providers no longer need to depend solely on the fetal heart rate, allowing them to make better-informed decisions and provide improved patient care.
Sector
Medical Device
Co-Investors:
Cross Border Impact Ventures, Avestria Ventures, RH Capital, Steel Sky Ventures, March of Dimes
Date
Q2 2024
Location
San Francisco Bay Area
Theme
Women’s Health
Nicolette's patented technology mines raw NICU patient data from the EHR and transforms it into easy to use tool that gives patients and their families the superpower to self-advocate. Reducing hospital length of stay and readmission rates in the NICU, and turning parents into partners and collaborators in care.
Sector
Digital Health, Medical AI
Co-Investors:
Cedar-Sinai Accelerator, Techstars, Wavemaker360 Health
Date
Q2 2023
Location
Southern California
Theme
Pediatrics
Sober Sidekick’s patented “empathy algorithm” allows those who are recovering from substance abuse to instantly connect and receive support from others in the sober community and get the support they need when they need it. Instead of sending people to rehab, Sober Sidekick partners with the healthcare payers themselves to help people get - and stay, sober.
Sector
Digital Health
Co-Investors
Nina Capital, American Heart Association
Date
Q2 2024
Location
Bentonville, Arkansas
Themes
Addiction, Data
Tenzr Health increases the effectiveness of physical therapy recovery by gamifying the at-home rehab experience. Improving compliance and outcomes and helping clinics generate additional revenue through Remote Therapeutic Monitoring.
Sector
Digital Health, Medtech
Co-Investors
Mayo Clinic, Particular Ventures, Kereitsu Forum, Health Equity Angels
Date
Q3 2022
Location
Seattle, Washington
TheraB Medical is developing the SnugLit™ Portable Phototherapy System. SnugLit is the only portable, wearable phototherapy garment for the treatment of jaundice that keeps babies in their mother’s arms, increasing bonding & breastfeeding without interrupting treatment. Developed in collaboration with over 350 nurses, doctors, and parents, SnugLit delivers a better treatment experience for families & a more cost-effective solution for medical providers in the hospital or at home.
Sector
Medtech
Co-Investors
Steel Sky Ventures, SmartGate VC, Health Equity Angels
Date
Q3 2023
Location
New Jersey
Themes
Pediatrics, Global Health
BetterMeal AI is a spearhead in Gut health, Omics, and artificial intelligence that reveals the connection between the gut universe and food to help restore human health. The helps users identify foods that specifically work for your personalized Gut and heal issues like PCOS, Thyroid, Type 2 Diabetes, IBD, Ulcerative Colitis, Crohn's disease, and Celiac. Understanding food at the molecular level, finding unique insights into food’s connection with our bodies. The unexplored depths of Gut health identifies the inflammatory markers earlier, so they can be healed.
Sector
Digital Health, Medical AI
Co-Investors
Sandhill Angels
Date
Q3 2022
Location
San Francisco Bay Area
Themes
Microbiome, Food as Medicine
Talamus Health
In emerging markets, lack of existing infrastructure makes it difficult for patients to access providers and pharmacies. Talamus is a mobile-first, hybrid cloud healthcare data platform that links patients to a comprehensive healthcare services value chain.
Sector
Digital Health, Medical AI
Co-Investors
Google for Startups - Black Founders Fund, Bill and Melinda Gates Foundation
Date
Q3 2022
Location
San Francisco Bay Area
Themes
Global Health, Africa
almon
therapeutics
Dry Age Related Macular Degeneration is a degenerative condition of the retina with no treatment and no cure. The condition is wide spread globally, onset of the condition will eventually cause blindness and 80% of AMD cases are the dry form. Almon Therapeutics has developed a combination therapy which regulates bioenergetic failure within the retina to halt the progression of AMD.
Sector
Therapeutic
Date
Q3 2022
Location
Southern California
Themes
Global Health